A small amount of fat does not affect piperaquine exposure in patients with malaria.

A small amount of fat does not affect piperaquine exposure in patients with malaria.

他のバージョン（1件）を表示する

Dihydroartemisinin-piperaquine is a new, highly effective, and well-tolerated combination treatment for uncomplicated falciparum malaria. The lipophilic characteristic of piperaquine suggests that administration together with fat will increase the oral bioavailability of the drug, and this has been...

書誌詳細
主要な著者:	Annerberg, A, Lwin, K, Lindegardh, N, Khrutsawadchai, S, Ashley, E, Day, N, Singhasivanon, P, Tarning, J, White, N, Nosten, F
フォーマット:	Journal article
言語:	English
出版事項:	2011

類似資料

A small amount of fat does not affect piperaquine exposure in patients with malaria.
著者:: Annerberg, A, 等
出版事項: (2011)

Population pharmacokinetic assessment of the effect of food on piperaquine bioavailability in patients with uncomplicated malaria.
著者:: Tarning, J, 等
出版事項: (2014)

Comparison of plasma, venous and capillary blood levels of piperaquine in patients with uncomplicated falciparum malaria.
著者:: Ashley, E, 等
出版事項: (2010)

Comparison of plasma, venous and capillary blood levels of piperaquine in patients with uncomplicated falciparum malaria
著者:: Ashley, E, 等
出版事項: (2010)

Pitfalls in estimating piperaquine elimination.
著者:: Tarning, J, 等
出版事項: (2005)

Population pharmacokinetics of piperaquine after two different treatment regimens of dihydroartemisinin piperaquine in patients with acute uncomplicated falciparum malaria in Thailand
著者:: Tarning, J, 等
出版事項: (2007)

Population pharmacokinetics of piperaquine after two different treatment regimens with dihydroartemisinin-piperaquine in patients with Plasmodium falciparum malaria in Thailand.
著者:: Tarning, J, 等
出版事項: (2008)

Randomized, double-blind, placebo-controlled trial of monthly versus bimonthly dihydroartemisinin-piperaquine chemoprevention in adults at high risk of malaria
著者:: Lwin, K, 等
出版事項: (2012)

Randomized, double-blind, placebo-controlled trial of monthly versus bimonthly dihydroartemisinin-piperaquine chemoprevention in adults at high risk of malaria.
著者:: Lwin, K, 等
出版事項: (2012)

Population pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated malaria.
著者:: Tarning, J, 等
出版事項: (2012)

Population Pharmacokinetics and Antimalarial Pharmacodynamics of Piperaquine in Patients With Plasmodium vivax Malaria in Thailand.
著者:: Tarning, J, 等
出版事項: (2014)

Population pharmacokinetics and antimalarial pharmacodynamics of piperaquine in patients with plasmodium vivax malaria in Thailand
著者:: Tarning, J, 等
出版事項: (2014)

Dihydroartemisinin-piperaquine versus chloroquine in the treatment of Plasmodium vivax malaria in Thailand: a randomized controlled trial.
著者:: Phyo, A, 等
出版事項: (2011)

Population Pharmacokinetics of Dihydroartemisinin and Piperaquine in Pregnant and Nonpregnant Women with Uncomplicated Malaria
著者:: Tarning, J, 等
出版事項: (2012)

Pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated falciparum malaria.
著者:: Rijken, M, 等
出版事項: (2011)

Characterization of an in vivo concentration-effect relationship for piperaquine in malaria chemoprevention.
著者:: Bergstrand, M, 等
出版事項: (2014)

Development and validation of a liquid chromatographic-tandem mass spectrometric method for determination of piperaquine in plasma stable isotope labeled internal standard does not always compensate for matrix effects.
著者:: Lindegardh, N, 等
出版事項: (2008)

Development and validation of an automated solid phase extraction and liquid chromatographic method for the determination of piperaquine in urine.
著者:: Tarning, J, 等
出版事項: (2006)

Population pharmacokinetics and pharmacodynamics of piperaquine in children with uncomplicated falciparum malaria.
著者:: Tarning, J, 等
出版事項: (2012)

Population pharmacokinetics and pharmacodynamics of piperaquine in children with uncomplicated falciparum malaria
著者:: Tarning, J, 等
出版事項: (2012)

Pharmacokinetics of piperaquine in pregnant women in Sudan with uncomplicated Plasmodium falciparum malaria.
著者:: Adam, I, 等
出版事項: (2012)

Efficacy and day 7 plasma piperaquine concentrations in African children treated for uncomplicated malaria with dihydroartemisinin-piperaquine
著者:: Zongo, I, 等
出版事項: (2014)

Pharmacokinetics of piperaquine in pregnant women in Sudan with uncomplicated Plasmodium falciparum malaria
著者:: Adam, I, 等
出版事項: (2012)

A population pharmacokinetic model of piperaquine in pregnant and non-pregnant women with uncomplicated Plasmodium falciparum malaria in Sudan.
著者:: Hoglund, R, 等
出版事項: (2012)

Quantification of the antimalarial piperaquine in plasma.
著者:: Tarning, J, 等
出版事項: (2008)

A RANDOMISED, DOUBLE-BLIND PLACEBO CONTROLLED TRIAL OF TWO DIFFERENT DOSING REGIMENS OF DIHYDROARTEMISININ-PIPERAQUINE FOR INTERMITTENT PREVENTIVE TREATMENT OF ADULTS AT HIGH RISK OF MALARIA IN THAILAND
著者:: Lwin, K, 等
出版事項: (2010)

Pharmacokinetic evaluation and metabolite characterization of the antimalarial piperaquine in the rat
著者:: Tarning, J, 等
出版事項: (2007)

Pharmacokinetics and metabolism of the antimalarial piperaquine after intravenous and oral single doses to the rat.
著者:: Tarning, J, 等
出版事項: (2008)

Electrocardiographic safety evaluation of dihydroartemisinin piperaquine in the treatment of uncomplicated falciparum malaria.
著者:: Mytton, O, 等
出版事項: (2007)

Characterization of human urinary metabolites of the antimalarial piperaquine.
著者:: Tarning, J, 等
出版事項: (2006)

Population pharmacokinetics of lumefantrine in pregnant women treated with artemether-lumefantrine for uncomplicated Plasmodium falciparum malaria.
著者:: Tarning, J, 等
出版事項: (2009)

Efficacy and safety of dihydroartemisinin-piperaquine.
著者:: Myint, H, 等
出版事項: (2007)

Efficacy and day 7 plasma piperaquine concentrations in African children treated for uncomplicated malaria with dihydroartemisinin-piperaquine.
著者:: Issaka Zongo, 等
出版事項: (2014-01-01)

A population pharmacokinetic model of piperaquine in pregnant and non-pregnant women with uncomplicated <it>Plasmodium falciparum</it> malaria in Sudan
著者:: Hoglund Richard M, 等
出版事項: (2012-11-01)

How much fat is necessary to optimize lumefantrine oral bioavailability?
著者:: Ashley, E, 等
出版事項: (2007)

Efficacy and effectiveness of dihydroartemisinin-piperaquine versus artesunate-mefloquine in falciparum malaria: an open-label randomised comparison.
著者:: Smithuis, F, 等
出版事項: (2006)

Population pharmacokinetic properties of Piperaquine in Falciparum Malaria: an individual participant data-level meta-analysis
著者:: Hoglund, R, 等
出版事項: (2017)

Dihydroartemisinin - piperaquine rescue treatment of multidrug-resistant Plasmodium falciparum malaria in pregnancy: a preliminary report
著者:: Rijken, M, 等
出版事項: (2007)

Optimal dosing of dihydroartemisinin-piperaquine for seasonal malaria chemoprevention in young children
著者:: Chotsiri, P, 等
出版事項: (2019)

Dihydroartemisinin-piperaquine versus chloroquine to treat vivax malaria in Afghanistan: an open randomized, non-inferiority, trial.
著者:: Awab, G, 等
出版事項: (2010)